IB Acquisition Corp(IBAC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.09 | Insider Own | 76.96% | Shs Outstand | 5.0M | Perf Week | -0.28% |
| Market Cap | 0.05B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 1.1M | Perf Month | -0.46% |
| Enterprise Value | 0.05B | PEG | - | EPS next Q | - | Inst Own | 9.39% | Short Float | 0.21% | Perf Quarter | 0.19% |
| Income | -0.00B | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 1.07 | Perf Half Y | - |
| Sales | 0.00B | P/B | 8.93 | EPS next 5Y | - | ROA | -0.61% | Short Interest | 0.00M | Perf YTD | 3.14% |
| Book/sh | 1.21 | P/C | 1799.72 | EPS past 3/5Y | - | ROE | -0.63% | 52W High | -6.96% ($11.64) | Perf Year | 3.93% |
| Cash/sh | 0.01 | P/FCF | - | Sales past 3/5Y | - | ROIC | -6.58% | 52W Low | 6.28% ($10.19) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -137.33% | Gross Margin | - | Volatility(W/M) | 0.04% 0.43% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.07 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.1 | EPS Q/Q | -317.69% | Profit Margin | - | RSI (14) | 44.86 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.1 | Sales Q/Q | - | SMA20 | -0.89% ($10.93) | Beta | 0 | Target Price | - |
| Payout | - | Debt/Eq | 0.08 | Earnings | - | SMA50 | -0.79% ($10.92) | Rel Volume | 0 | Prev Close | $10.93 |
| Employees | 2 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | 1.17% ($10.7) | Avg Volume(3M) | 0.00M | Price | $10.83 |
| IPO | 2024/5/1 | Option/Short | No/Yes | Trades | 4 | Volume | 8 | Change | -0.91% |
A special purpose acquisition company (SPAC) that aims to drive innovation in the biotech market by merging with GNQ Insilico, an AI-powered drug discovery platform company.
Over the past 1 year, roughly in the middle
7% below its 1-year high.
Traded less than usual. That is 0% of its average volume.
Company yardsticks do not fit here, so profitability, valuation and earnings are left out. The other verdicts still apply.
Long-term returns are roughly flat
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 9.4%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #1344 of 1436 in the industry
Based on market cap of $54M.
PDCC#1338 Pearl Diver Credit Company Inc $59M PER - 
ZSTK#1342 ZeroStack Corp $55M PER - IBAC#1344 IB Acquisition Corp $54M PER - 
DPU#1345 Nexpu Ltd $54M PER - 
DTCX#1348 Datacentrex Inc $50M PER - 
FAQ
What kind of company is IBAC?
IBAC belongs to the Financial sector and operates in the Shell Companies industry.
What is the market cap of IBAC?
The market cap of IBAC is approximately $54M, ranking 4,792 within its sector.
What is the 52-week high and low for IBAC?
IBAC has recorded a 52-week high of $11.64 and a low of $10.19.
